Tagged Articles

Omnicare 3 articles

The Fraud List: Omnicare Inc., King of Kickbacks

The Fraud List

The pharmacy benefit management industry is ferociously competitive. These companies process prescription drugs and pharmacy services to insurance companies, nursing homes, and other clients, using their size and clout to negotiate lower prices. Cincinnati-headquartered Omnicare Inc. is the largest provider of prescription drugs and pharmacy consulting services to nursing homes and other long-term care facilities in the U.S.  It is also one of the top violators of federal laws designed to protect the integrity and viability of Medicare, Medicaid, and other taxpayer-funded government health care programs. Omnicare’s rap sheet shows that for more than a decade, the company has engaged ... Read More

Johnson & Johnson agrees to a settlement of $2.2 billion to end U.S. investigations

Pharmaceutical giant Johnson & Johnson, and its subsidiaries, has agreed to pay $2.2 billion in an effort to end civil and criminal investigations into kickbacks the company allegedly paid to pharmacists and physicians to promote three prescription drugs for off-label uses unapproved by the U.S. Food and Drug Administration (FDA), according to the Department of Justice. The settlement involved the marketing of Risperdal and Invega, both drugs originally designated for schizophrenia and bipolar disorder treatment, and the heart failure drug, Natrecor. This is one of the largest health care fraud settlements in U.S. history. Risperdal, sold by J&J firm Janssen Pharmaceuticals, ... Read More

Johnson and Johnson to pay up to $2.2 billion in Risperdal lawsuit

Pharmaceutical giant Johnson & Johnson has agreed to pay as much as $2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal. The lawsuit claims Johnson & Johnson paid kickbacks to a company that provided prescription drugs to nursing home patients in order to increase the sales of Risperdal, a drug approved to treat symptoms of schizophrenia and bipolar disorder. The drug has been associated with an increased risk of death in elderly people with dementia. The settlement will include a $400 million criminal fine. The final amount Johnson & Johnson pays will be determined by how many ... Read More